164 related articles for article (PubMed ID: 34359966)
1. Development and Validation of a Good Manufacturing Process for IL-4-Driven Expansion of Chimeric Cytokine Receptor-Expressing CAR T-Cells.
van Schalkwyk MCI; van der Stegen SJC; Bosshard-Carter L; Graves H; Papa S; Parente-Pereira AC; Farzaneh F; Fisher CD; Hope A; Adami A; Maher J
Cells; 2021 Jul; 10(7):. PubMed ID: 34359966
[TBL] [Abstract][Full Text] [Related]
2. GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR.
Straetemans T; Kierkels GJJ; Doorn R; Jansen K; Heijhuurs S; Dos Santos JM; van Muyden ADD; Vie H; Clemenceau B; Raymakers R; de Witte M; Sebestyén Z; Kuball J
Front Immunol; 2018; 9():1062. PubMed ID: 29899740
[TBL] [Abstract][Full Text] [Related]
3. Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cells.
Yoshikawa T; Ito Y; Wu Z; Kasuya H; Nakashima T; Okamoto S; Amaishi Y; Zhang H; Li Y; Matsukawa T; Inoue S; Kagoya Y
Cell Rep Med; 2024 May; 5(5):101526. PubMed ID: 38670095
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study.
Papa S; Adami A; Metoudi M; Beatson R; George MS; Achkova D; Williams E; Arif S; Reid F; Elstad M; Beckley-Hoelscher N; Douri A; Delord M; Lyne M; Shivapatham D; Fisher C; Hope A; Gooljar S; Mitra A; Gomm L; Morton C; Henley-Smith R; Thavaraj S; Santambrogio A; Andoniadou C; Allen S; Gibson V; Cook GJR; Parente-Pereira AC; Davies DM; Farzaneh F; Schurich A; Guerrero-Urbano T; Jeannon JP; Spicer J; Maher J
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37321663
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two lab-scale protocols for enhanced mRNA-based CAR-T cell generation and functionality.
von Auw N; Serfling R; Kitte R; Hilger N; Zhang C; Gebhardt C; Duenkel A; Franz P; Koehl U; Fricke S; Tretbar US
Sci Rep; 2023 Oct; 13(1):18160. PubMed ID: 37875523
[TBL] [Abstract][Full Text] [Related]
6. Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation.
Capsomidis A; Benthall G; Van Acker HH; Fisher J; Kramer AM; Abeln Z; Majani Y; Gileadi T; Wallace R; Gustafsson K; Flutter B; Anderson J
Mol Ther; 2018 Feb; 26(2):354-365. PubMed ID: 29310916
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of IL-4/IL-15-based inverted cytokine receptor in CAR-T cells overcomes IL-4 signaling in immunosuppressive pancreatic tumor microenvironment.
Zhou Y; Farooq MA; Ajmal I; He C; Gao Y; Guo D; Duan Y; Jiang W
Biomed Pharmacother; 2023 Dec; 168():115740. PubMed ID: 37865999
[TBL] [Abstract][Full Text] [Related]
8. Development of a microfluidic cell transfection device into gene-edited CAR T cell manufacturing workflow.
Yu T; Jhita N; Shankles P; Fedanov A; Kramer N; Raikar SS; Sulchek T
Lab Chip; 2023 Nov; 23(22):4804-4820. PubMed ID: 37830228
[TBL] [Abstract][Full Text] [Related]
9. A quality-by-design approach to improve process understanding and optimise the production and quality of CAR-T cells in automated stirred-tank bioreactors.
Hood T; Slingsby F; Sandner V; Geis W; Schmidberger T; Bevan N; Vicard Q; Hengst J; Springuel P; Dianat N; Rafiq QA
Front Immunol; 2024; 15():1335932. PubMed ID: 38655265
[No Abstract] [Full Text] [Related]
10. Automated production of gene-modified chimeric antigen receptor T cells using the Cocoon Platform.
Trainor N; Purpura KA; Middleton K; Fargo K; Hails L; Vicentini-Hogan M; McRobie C; Daniels R; Densham P; Gardin P; Fouks M; Brayer H; Malka RG; Rodin A; Ogen T; Besser MJ; Smith T; Leonard D; Bryan A
Cytotherapy; 2023 Dec; 25(12):1349-1360. PubMed ID: 37690020
[TBL] [Abstract][Full Text] [Related]
11. CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans.
Nicod C; da Rocha MN; Warda W; Roussel X; Haderbache R; Seffar E; Trad R; Bouquet L; Goncalves M; Bosdure L; Laude MC; Guiot M; Ferrand C; Deschamps M
Curr Res Transl Med; 2023; 71(2):103385. PubMed ID: 36773434
[TBL] [Abstract][Full Text] [Related]
12. Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor.
Machietto R; Giacobbe N; Perazzelli J; Hofmann TJ; Barz Leahy A; Grupp SA; Wang Y; Kadauke S
J Vis Exp; 2023 Aug; (198):. PubMed ID: 37607096
[TBL] [Abstract][Full Text] [Related]
13. Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies.
Nowakowska P; Romanski A; Miller N; Odendahl M; Bonig H; Zhang C; Seifried E; Wels WS; Tonn T
Cancer Immunol Immunother; 2018 Jan; 67(1):25-38. PubMed ID: 28879551
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the importance of culture pH on CD22 CAR T-cells characteristics.
Prochazkova M; Dreyzin A; Shao L; Garces P; Cai Y; Shi R; Pelayo A; Kim YS; Pham V; Frodigh SE; Fenton S; Karangwa C; Su Y; Martin K; Zhang N; Highfill SL; Somerville RP; Shah NN; Stroncek DF; Jin P
J Transl Med; 2024 Apr; 22(1):384. PubMed ID: 38659083
[TBL] [Abstract][Full Text] [Related]
15. Inducing T cell dysfunction by chronic stimulation of CAR-engineered T cells targeting cancer cells in suspension cultures.
Selli ME; Landmann JH; Arveseth C; Singh N
STAR Protoc; 2023 Mar; 4(1):101954. PubMed ID: 36607811
[TBL] [Abstract][Full Text] [Related]
16. Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells.
Netsrithong R; Wattanapanitch M
Front Immunol; 2021; 12():759558. PubMed ID: 34650571
[TBL] [Abstract][Full Text] [Related]
17. Use of polyvinyl alcohol for chimeric antigen receptor T-cell expansion.
Nishimura T; Hsu I; Martinez-Krams DC; Nakauchi Y; Majeti R; Yamazaki S; Nakauchi H; Wilkinson AC
Exp Hematol; 2019 Dec; 80():16-20. PubMed ID: 31874780
[TBL] [Abstract][Full Text] [Related]
18. A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice.
Jin G; Liu Y; Wang L; He Z; Zhao X; Ma Y; Jia Y; Li Z; Yin N; Peng M
Nat Immunol; 2024 Jun; 25(6):1059-1072. PubMed ID: 38802511
[TBL] [Abstract][Full Text] [Related]
19. CD8
Lee SY; Lee DH; Sun W; Cervantes-Contreras F; Basom RS; Wu F; Liu S; Rai R; Mirzaei HR; O'Steen S; Green DJ; Shadman M; Till BG
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38251688
[TBL] [Abstract][Full Text] [Related]
20. Cryopreserved leukapheresis material can be transferred from controlled rate freezers to ultracold storage at warmer temperatures without affecting downstream CAR-T cell culture performance and in-vitro functionality.
Wei J; Chaney K; Shim WJ; Chen H; Leonard G; O'Brien S; Liu Z; Jiang J; Ulrey R
Cryobiology; 2024 Jun; 115():104889. PubMed ID: 38513998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
